Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grupo Arcor is an Argentine multinational conglomerate that has strategically expanded from its core confectionery business into the consumer healthcare and life sciences sector. Through a high-profile joint venture with Laboratorios Bagó, the company developed the "Simple" line of nutraceuticals, which utilizes advanced food technology to deliver therapeutic doses of vitamins, minerals, and probiotics in consumer-friendly formats. The company's healthcare portfolio targets common wellness indications such as bone density, digestive health, and immune resilience. Arcor's extensive R&D and manufacturing infrastructure in Latin America supports its growth in the functional foods market, positioning it as a key player in the convergence of nutrition and pharmacology. The company operates over 40 industrial plants and maintains a presence in more than 120 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grupo Arcor.